Clinical impairment index

1. DunedinPACE predicts clinical impairment index in humans (AUC = 0.73, 95% CI (0.57-0.88)).

   “DunedinPACE [AUC = 0.73, 95% CI (0.57-0.88); p = < 0.01] measures showed the greatest potential to identify clinical frailty using the I2.”

   Humansnewly diagnosed with hematologic malignanciesperipheral blood T lymphocytesn = 70

   Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy

   Journal of cancer survivorship : research and practice·Apr 28, 2024

More on DunedinPACE

1. CDKN2A predicts clinical impairment index in humans (AUC = 0.76, 95% CI (0.56-0.98)).

   “baseline p16INK4a [AUC = 0.76, 95% CI (0.56-0.98); p = 0.01]”

   Humansnewly diagnosed with hematologic malignanciesperipheral blood T lymphocytesn = 70

   Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy

   Journal of cancer survivorship : research and practice·Apr 28, 2024

More on CDKN2A